<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Current management of primary or secondary <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> (aPL) syndromes with known embolic phenomena requiring anticoagulation is empiric in the setting of elective orthopedic procedures </plain></SENT>
<SENT sid="1" pm="."><plain>Short-term withdrawal of <z:chebi fb="8" ids="10033">warfarin</z:chebi> with continuance of aspirin and <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> therapy was undertaken for sequential bilateral knee replacements in a <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> patient with aPL </plain></SENT>
<SENT sid="2" pm="."><plain>Her course was successfully managed without thrombo-embolic complications </plain></SENT>
</text></document>